MicroRNA profiling with correlation to gene expression revealed the oncogenic miR-17-92 cluster to be up-regulated in

Daniel Baumhoer1, Stephanie Zillmer, Kristian Unger

  • 1Bone Tumor Reference Center at the Institute of Pathology, University Hospital Basel, Switzerland. dbaumhoer@mac.com

Cancer Genetics
|June 12, 2012
PubMed

Insights

MicroRNAs (miRNAs) play a key role in osteosarcoma development. Deregulated miRNA expression significantly impacts gene expression, offering potential therapeutic targets for this complex bone cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Osteosarcomas are complex bone cancers with poorly understood molecular mechanisms.
  • MicroRNAs (miRNAs) are increasingly recognized as key regulators of tumor development.
  • Gene expression alterations are common in osteosarcoma, but their miRNA-driven causes are unclear.

Purpose of the Study:

  • To investigate genome-wide miRNA expression in osteosarcoma cell lines.
  • To correlate miRNA expression with gene expression patterns in osteosarcoma.
  • To identify specific miRNAs with oncogenic or tumor suppressor roles in osteosarcoma.

Main Methods:

  • Analysis of miRNA expression profiles across six osteosarcoma cell lines.
  • Comparison of osteosarcoma miRNA expression with normal osteoblast and mesenchymal stem cell references.
  • Correlation of deregulated miRNA expression with known gene expression data.

Main Results:

  • Identified several deregulated miRNAs, including members of the oncogenic miR-17-92 cluster, in the majority of osteosarcoma cell lines.
  • Observed altered expression of genes involved in differentiation, cell cycle control, and apoptosis.
  • Linked gene expression changes to specific miRNA expression patterns in osteosarcoma.

Conclusions:

  • Deregulated miRNAs significantly impact gene expression in osteosarcomas.
  • These miRNA-gene expression interactions are crucial to osteosarcoma pathogenesis.
  • Findings suggest potential diagnostic and therapeutic implications for targeting miRNA pathways in osteosarcoma.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...